Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2012

Main Data: 31/12 Year 2012
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 734.31
– gross industrial income 304.38
– total operating cost 223.77
– operating profit 80.61
– net financial expenses 9.71
– group profit 47.70

 

Consolidated balance sheet Millions/Euro
– working capital 59.36
– non-current assets 240.26
– provision for severance indemnities and other provisions -9.69
– net debt -131.47
– equity pertaining to the group and minority interests 158.46

 

Other information Millions/Euro
– depreciation, amortization and impairment 24.19
– R & D costs 33.69

 

  Euro
Dividend per share 1.00

 

  No.
Employees 3,545

 

  Euro
Share capital 19,150,560

 

Main Data: 30/06 Year 2012
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 335.5
– gross industrial income 135.8
– total operating cost 109.4
– operating profit 26.4
– net financial expenses 4.8
– group profit (loss) 12.2

 

Consolidated balance sheet Millions/Euro
– working capital 113.9
– non-current assets 240.6
– provision for severance indemnities and other provisions – 20.1
– net debt – 209.6
– equity pertaining to the group and minority interests 124.8

 

Other information Millions/Euro
– depreciation, amortization and impairment 9.6
– R & D costs 16.6

 

  No.
Employees 3,524

 

  Euro
Share capital 19,150,560

 

Net Sales by Sector: Year 2012
  Millions/Euro  
tea, food & other 280.14 38.2%
pharmaceutical 454.17 61.8%
Total 734.31 100.0%

 

Net Sales by Country: Year 2012
  Millions/Euro  
E.U. (excluding Italy) 246.84 33.6%
Other European countries 76.35 10.4%
North America 95.99 13.1%
Asia & Middle East 166.31 22.6%
Other countries 95.88 13.1%
Total exports 681.37 92.8%
Italy 52.94 7.2%
Total 734.31 100.0%